The Effect of Remdesivir in Patients with Severe COVID-19, Reporting Case Series
Open Access
- 28 November 2021
- journal article
- Published by Briefland in Shiraz E-Medical Journal
- Vol. 23 (4)
- https://doi.org/10.5812/semj.116995
Abstract
Keywords Severity COVID-19 RemdesivirKeywords
This publication has 14 references indexed in Scilit:
- Remdesivir for the Treatment of Covid-19 — Final ReportThe New England Journal of Medicine, 2020
- Mild or Moderate Covid-19The New England Journal of Medicine, 2020
- The Association of Non-Steroidal Anti-Inflammatory Drugs with COVID-19 Severity and MortalityArchives of Clinical Infectious Diseases, 2020
- Compassionate Use of Remdesivir in Covid-19The New England Journal of Medicine, 2020
- Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation statusPharmacological Research, 2020
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet, 2020
- Candidate drugs against SARS-CoV-2 and COVID-19Pharmacological Research, 2020
- Coronavirus Disease 2019 Treatment: A Review of Early and Emerging OptionsOpen Forum Infectious Diseases, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingThe Lancet, 2020